Industry Conference

NCR Voyix is launching a new AI-driven, microservices-based platform designed to help restaurants combat labor shortages and meet rising customer expectations.

With promising data in hard-to-treat cancers, iOnctura's lead drug, roginolisib, is set to make waves at the top healthcare investment forum.

After a major business sale, Elutia is launching NXT-41x, an antibiotic biomatrix designed to combat the high rate of infection in breast reconstruction.

As Mammoth Biosciences preps for JPM, its ultracompact CRISPR tech aims to redefine in vivo gene therapy, promising cures for diseases beyond the liver.

Lightspeed's new conversational AI acts as a business partner for retailers and restaurants, turning complex data into simple answers to boost performance.

With $82M in funding and novel gene insertion technology, Averna Therapeutics is poised to make waves at the pivotal J.P. Morgan Healthcare Conference.

At CES 2026, Chinese startup KunlunMeta and AMD launched a portable AI terminal, promising unprecedented mobile productivity and data privacy.

At AIMExpo 2026, ASMAX unveiled a rider-centric IoT ecosystem, aiming to redefine group communication and safety with advanced mesh and AI technology.

With a 70-year legacy, Godrej targets the Middle East's booming market at Intersec 2026, showcasing smart, certified, and sustainable security solutions.

As Valneva meets investors, all eyes are on its pivotal Lyme disease vaccine data, a potential game-changer for public health and the company's future.

FieldBee Vision's gold medal win at LAMMA 2026 signals a new era of accessible, AI-driven precision agriculture for farms of all sizes.

From firefighting robots to AI health diagnostics, Hong Kong's record delegation at CES 2026 wins big, signaling its arrival as a global tech powerhouse.

A new partnership merges a revolutionary centrifugal 3D printer with advanced materials, aiming to slash dental lab labor and cycle times by 90%.

Idomoo, Poppulo, and AWS unveil AI that brings hyper-personalized video ads to physical stores, adapting in real time to shoppers and inventory.

The National Retail Federation partners with Insider One, using advanced AI to personalize its massive 2026 trade show for 40,000 attendees.

Klotho Neurosciences will present its novel gene therapy for Alzheimer's and ALS at a key summit, seeking to turn scientific promise into clinical reality.

Accenture's new investment in Profitmind's agentic AI platform signals a major shift for retail, promising to automate complex decisions and bridge the gap between data and action.

The new x-hoppers mobile app bridges the gap between the frontline and back office, creating a unified, AI-powered communication network for all staff.

EF Adventures' new Tour de France tours let fans ride race routes and party with pros, setting a new standard for immersive sports tourism.

With major backing from Goldman Sachs, a biotech firm is advancing a potentially life-changing gene therapy for a rare, progressive form of blindness.